Search results
BioNJ Announces Lineup for BioPartnering Conference
FOX 59 Indianapolis· 6 days agoConference on Tuesday, May 14, at the Liberty Science Center in Jersey City. Sponsored by J.P. Morgan, Johnson & Johnson and Morgan Lewis ...
GS1 Connect 2024 Agenda Offers Supply Chain Best Practices Across Retail, Grocery, Foodservice and...
WPRI Providence· 1 week agoGS1 Connect 2024, the conference and exhibition hosted by GS1 US, will feature more than 300 leading companies that...'s, Fresenius Kabi, General Mills, Johnson< ...
Andy Johnson
The National Law Review· 1 week agoAndy Johnson is an Attorney at Bradley Arant Boult Cummings LLP. Johnson practices defense of claims against companies that invent, design, manufacture and market co
‘Covert City’ Review: The Cold War in Miami
The Wall Street Journal· 5 days agoTaking advantage of these human resources, the authors write, “Dow Chemical, International Harvester, Eastman Kodak, Pfizer, and over twenty-five other...
Best biotech stocks to buy and hold in 2024: VKTX, SANA, RXRX
Invezz· 1 week agoJohnson & Johnson is acquiring Shockwave Medical while Novo Nordisk is buying Catalent, a CDMO...
U.S. regulators give full approval to Pfizer COVID-19 vaccine
AOL· 2 weeks agoU.S. gave full approval to Pfizer's COVID-19 vaccine on Monday, a milestone that may help lift public confidence in the shots as the nation battles the most contagious coronavirus ...
J&J, Bristol Myers lose challenges to US drug price negotiation program
Reuters via AOL· 2 days agoA U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law...
Peripheral Neuropathy Market is Expected to Hit USD 7.95 Billion by 2031
Digital Journal· 2 weeks agoAccording to SNS Insider, Peripheral Neuropathy Market is projected to reach USD 7.95 Billion by...
Big pharma: cautious optimism ahead of earnings season - analysts
Proactive Investors· 2 weeks agoLooking ahead to the pharmaceutical earnings season, UBS expressed cautious optimism when looking at...
...Expected to Reach USD 13.64 Billion by 2030 Predicts SNS Insider | Leading Companies – Abbott,...
Digital Journal· 5 days agoThe global Type 1 Diabetes Market, which was valued at USD 7.59 billion in 2022, is anticipated to...
